Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Amortization of Deferred Charges (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Amortization of Deferred Charges for 6 consecutive years, with $99849.0 as the latest value for Q2 2020.

  • Quarterly Amortization of Deferred Charges fell 76.17% to $99849.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $235636.0 through Jun 2020, down 83.52% year-over-year, with the annual reading at $2.7 million for FY2024, 6.01% up from the prior year.
  • Amortization of Deferred Charges for Q2 2020 was $99849.0 at Outlook Therapeutics, down from $120065.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.7 million in Q3 2017, with the low at $2504.0 in Q2 2016.
  • Average Amortization of Deferred Charges over 5 years is $405344.2, with a median of $230217.0 recorded in 2018.
  • The sharpest move saw Amortization of Deferred Charges skyrocketed 53110.98% in 2017, then tumbled 96.51% in 2019.
  • Over 5 years, Amortization of Deferred Charges stood at $140820.0 in 2016, then soared by 311.58% to $579586.0 in 2017, then fell by 22.29% to $450381.0 in 2018, then crashed by 96.51% to $15722.0 in 2019, then skyrocketed by 535.09% to $99849.0 in 2020.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $99849.0, $120065.0, and $15722.0 for Q2 2020, Q1 2020, and Q4 2019 respectively.